In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study

AIMS: Atrial fibrillation (AF) is a risk factor for brain infarction, which can lead to epilepsy. We aimed to investigate whether treatment of AF with direct oral anticoagulants (DOACs) affects the risk of epilepsy in comparison to treatment with the vitamin K antagonist phenprocoumon (PPC). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Platzbecker, Katharina, Müller-Fielitz, Helge, Foraita, Ronja, Koepp, Matthias J, Voss, Annemarie, Pflock, René, Linder, Roland, Pigeot, Iris, Schink, Tania, Schwaninger, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228540/
https://www.ncbi.nlm.nih.gov/pubmed/37013704
http://dx.doi.org/10.1093/europace/euad087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228540/
https://www.ncbi.nlm.nih.gov/pubmed/37013704
http://dx.doi.org/10.1093/europace/euad087

Ejemplares similares